International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain

Saved in:
Bibliographic Details
Published in:Cancer Immunology, Immunotherapy Immunotherapy, 2018-11, Vol.67 (11), p.1809-1813
Main Authors: Berraondo, Pedro, Aznar, Maria Angela, Perez-Ruiz, Elisabeth, Rodriguez-Ruiz, Maria Esperanza, Castañon, Eduardo, Perez-Gracia, Jose Luis, Melero, Ignacio
Format: Article
Language:English
Subjects:
Antibodies, Monoclonal - therapeutic use
Cancer
Cancer immunotherapy
Cancer Research
Congresses as Topic
Humans
Immunology
Immunotherapy
International Agencies
Medicine
Medicine & Public Health
Meeting Report
Neoplasms - immunology
Neoplasms - therapy
Oncology
Spain
T-Lymphocytes, Cytotoxic
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 1813
container_issue 11
container_start_page 1809
container_title Cancer Immunology, Immunotherapy
container_volume 67
creator Berraondo, Pedro
Aznar, Maria Angela
Perez-Ruiz, Elisabeth
Rodriguez-Ruiz, Maria Esperanza
Castañon, Eduardo
Perez-Gracia, Jose Luis
Melero, Ignacio
description
doi_str_mv 10.1007/s00262-018-2240-y
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11028187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2099248152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c380t-b976f5de9fde42d98bb3d02848c87e6ca15d3df26549c600db00e746c4e088103</originalsourceid><addsrcrecordid>eNp1kc1u1DAUha0K1A6FB-gGWWLDYkKvHSdx2FTViJ-RKhWpZW05jjN15djBTiqFFe_AG_IkeJTSAlJXtu79zrn2PQidEHhHAKrTCEBLmgHhGaUMsvkArQjLU4UX5BlaQZ6KFQA7Qi9ivE0XCnV9iI7yJKGUkxXSWzfq4ORovJMWX8394KOZ-vf4OkhjGyu_G7fDxuGNdEoHvO37yfnxRgc5zGt8qUbfpDKtf_34mZM1pkCqNf4i-8EmxzW-GqRxL9HzTtqoX92fx-jrxw_Xm8_ZxeWn7eb8IlM5hzFr6qrsilbXXasZbWveNHkLlDOueKVLJUnR5m1Hy4LVqgRoGwBdsVIxDZwTyI_R2eI7TE2vW6XdGKQVQzC9DLPw0oh_O87ciJ2_E4SkMYRXyeHtvUPw3yYdR9GbqLS10mk_RbFfIOcVr2lC3_yH3voprdIuFGWcFHuKLJQKPsagu4fXEBD7FMWSokiRiH2KYk6a139_40HxJ7YE0AWIqeV2OjyOftr1N4RJqDM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2099248152</pqid></control><display><type>article</type><title>International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain</title><source>Open Access: PubMed Central</source><source>Springer Nature</source><creator>Berraondo, Pedro ; Aznar, Maria Angela ; Perez-Ruiz, Elisabeth ; Rodriguez-Ruiz, Maria Esperanza ; Castañon, Eduardo ; Perez-Gracia, Jose Luis ; Melero, Ignacio</creator><creatorcontrib>Berraondo, Pedro ; Aznar, Maria Angela ; Perez-Ruiz, Elisabeth ; Rodriguez-Ruiz, Maria Esperanza ; Castañon, Eduardo ; Perez-Gracia, Jose Luis ; Melero, Ignacio</creatorcontrib><identifier>ISSN: 0340-7004</identifier><identifier>EISSN: 1432-0851</identifier><identifier>DOI: 10.1007/s00262-018-2240-y</identifier><identifier>PMID: 30182281</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Antibodies, Monoclonal - therapeutic use ; Cancer ; Cancer immunotherapy ; Cancer Research ; Congresses as Topic ; Humans ; Immunology ; Immunotherapy ; International Agencies ; Medicine ; Medicine &amp; Public Health ; Meeting Report ; Neoplasms - immunology ; Neoplasms - therapy ; Oncology ; Spain ; T-Lymphocytes, Cytotoxic</subject><ispartof>Cancer Immunology, Immunotherapy, 2018-11, Vol.67 (11), p.1809-1813</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2018</rights><rights>Cancer Immunology, Immunotherapy is a copyright of Springer, (2018). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><orcidid>0000-0003-4941-9075 ; 0000-0001-7410-1865 ; 0000-0002-7970-1672 ; 0000-0002-1360-348X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11028187/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11028187/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,725,778,782,883,27907,27908,53774,53776</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30182281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Berraondo, Pedro</creatorcontrib><creatorcontrib>Aznar, Maria Angela</creatorcontrib><creatorcontrib>Perez-Ruiz, Elisabeth</creatorcontrib><creatorcontrib>Rodriguez-Ruiz, Maria Esperanza</creatorcontrib><creatorcontrib>Castañon, Eduardo</creatorcontrib><creatorcontrib>Perez-Gracia, Jose Luis</creatorcontrib><creatorcontrib>Melero, Ignacio</creatorcontrib><title>International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain</title><title>Cancer Immunology, Immunotherapy</title><addtitle>Cancer Immunol Immunother</addtitle><addtitle>Cancer Immunol Immunother</addtitle><subject>Antibodies, Monoclonal - therapeutic use</subject><subject>Cancer</subject><subject>Cancer immunotherapy</subject><subject>Cancer Research</subject><subject>Congresses as Topic</subject><subject>Humans</subject><subject>Immunology</subject><subject>Immunotherapy</subject><subject>International Agencies</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Meeting Report</subject><subject>Neoplasms - immunology</subject><subject>Neoplasms - therapy</subject><subject>Oncology</subject><subject>Spain</subject><subject>T-Lymphocytes, Cytotoxic</subject><issn>0340-7004</issn><issn>1432-0851</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kc1u1DAUha0K1A6FB-gGWWLDYkKvHSdx2FTViJ-RKhWpZW05jjN15djBTiqFFe_AG_IkeJTSAlJXtu79zrn2PQidEHhHAKrTCEBLmgHhGaUMsvkArQjLU4UX5BlaQZ6KFQA7Qi9ivE0XCnV9iI7yJKGUkxXSWzfq4ORovJMWX8394KOZ-vf4OkhjGyu_G7fDxuGNdEoHvO37yfnxRgc5zGt8qUbfpDKtf_34mZM1pkCqNf4i-8EmxzW-GqRxL9HzTtqoX92fx-jrxw_Xm8_ZxeWn7eb8IlM5hzFr6qrsilbXXasZbWveNHkLlDOueKVLJUnR5m1Hy4LVqgRoGwBdsVIxDZwTyI_R2eI7TE2vW6XdGKQVQzC9DLPw0oh_O87ciJ2_E4SkMYRXyeHtvUPw3yYdR9GbqLS10mk_RbFfIOcVr2lC3_yH3voprdIuFGWcFHuKLJQKPsagu4fXEBD7FMWSokiRiH2KYk6a139_40HxJ7YE0AWIqeV2OjyOftr1N4RJqDM</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Berraondo, Pedro</creator><creator>Aznar, Maria Angela</creator><creator>Perez-Ruiz, Elisabeth</creator><creator>Rodriguez-Ruiz, Maria Esperanza</creator><creator>Castañon, Eduardo</creator><creator>Perez-Gracia, Jose Luis</creator><creator>Melero, Ignacio</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-4941-9075</orcidid><orcidid>https://orcid.org/0000-0001-7410-1865</orcidid><orcidid>https://orcid.org/0000-0002-7970-1672</orcidid><orcidid>https://orcid.org/0000-0002-1360-348X</orcidid></search><sort><creationdate>20181101</creationdate><title>International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain</title><author>Berraondo, Pedro ; Aznar, Maria Angela ; Perez-Ruiz, Elisabeth ; Rodriguez-Ruiz, Maria Esperanza ; Castañon, Eduardo ; Perez-Gracia, Jose Luis ; Melero, Ignacio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c380t-b976f5de9fde42d98bb3d02848c87e6ca15d3df26549c600db00e746c4e088103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Antibodies, Monoclonal - therapeutic use</topic><topic>Cancer</topic><topic>Cancer immunotherapy</topic><topic>Cancer Research</topic><topic>Congresses as Topic</topic><topic>Humans</topic><topic>Immunology</topic><topic>Immunotherapy</topic><topic>International Agencies</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Meeting Report</topic><topic>Neoplasms - immunology</topic><topic>Neoplasms - therapy</topic><topic>Oncology</topic><topic>Spain</topic><topic>T-Lymphocytes, Cytotoxic</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Berraondo, Pedro</creatorcontrib><creatorcontrib>Aznar, Maria Angela</creatorcontrib><creatorcontrib>Perez-Ruiz, Elisabeth</creatorcontrib><creatorcontrib>Rodriguez-Ruiz, Maria Esperanza</creatorcontrib><creatorcontrib>Castañon, Eduardo</creatorcontrib><creatorcontrib>Perez-Gracia, Jose Luis</creatorcontrib><creatorcontrib>Melero, Ignacio</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cancer Immunology, Immunotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Berraondo, Pedro</au><au>Aznar, Maria Angela</au><au>Perez-Ruiz, Elisabeth</au><au>Rodriguez-Ruiz, Maria Esperanza</au><au>Castañon, Eduardo</au><au>Perez-Gracia, Jose Luis</au><au>Melero, Ignacio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain</atitle><jtitle>Cancer Immunology, Immunotherapy</jtitle><stitle>Cancer Immunol Immunother</stitle><addtitle>Cancer Immunol Immunother</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>67</volume><issue>11</issue><spage>1809</spage><epage>1813</epage><pages>1809-1813</pages><issn>0340-7004</issn><eissn>1432-0851</eissn><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>30182281</pmid><doi>10.1007/s00262-018-2240-y</doi><tpages>5</tpages><orcidid>https://orcid.org/0000-0003-4941-9075</orcidid><orcidid>https://orcid.org/0000-0001-7410-1865</orcidid><orcidid>https://orcid.org/0000-0002-7970-1672</orcidid><orcidid>https://orcid.org/0000-0002-1360-348X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0340-7004
ispartof Cancer Immunology, Immunotherapy, 2018-11, Vol.67 (11), p.1809-1813
issn 0340-7004
1432-0851
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11028187
source Open Access: PubMed Central; Springer Nature
subjects Antibodies, Monoclonal - therapeutic use
Cancer
Cancer immunotherapy
Cancer Research
Congresses as Topic
Humans
Immunology
Immunotherapy
International Agencies
Medicine
Medicine & Public Health
Meeting Report
Neoplasms - immunology
Neoplasms - therapy
Oncology
Spain
T-Lymphocytes, Cytotoxic
title International Symposium: Trailblazing in Cancer Immunotherapy, October 29–31, 2017, Pamplona, Spain
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T05%3A07%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=International%20Symposium:%20Trailblazing%20in%20Cancer%20Immunotherapy,%20October%2029%E2%80%9331,%202017,%20Pamplona,%20Spain&rft.jtitle=Cancer%20Immunology,%20Immunotherapy&rft.au=Berraondo,%20Pedro&rft.date=2018-11-01&rft.volume=67&rft.issue=11&rft.spage=1809&rft.epage=1813&rft.pages=1809-1813&rft.issn=0340-7004&rft.eissn=1432-0851&rft_id=info:doi/10.1007/s00262-018-2240-y&rft_dat=%3Cproquest_pubme%3E2099248152%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c380t-b976f5de9fde42d98bb3d02848c87e6ca15d3df26549c600db00e746c4e088103%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2099248152&rft_id=info:pmid/30182281&rfr_iscdi=true